BURGESS DANIEL D — SEC Form 4 filings

SEC reporting owner CIK 1239650. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-07.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-05-24 to 2026-01-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Cidara Therapeutics, Inc. (CDTX)Director415
Arbutus Biopharma Corp (ABUS)Director11

Form 4 filings — BURGESS DANIEL D

FiledFormIssuerReported transactionsSource
2026-01-074Cidara Therapeutics, Inc. (CDTX)Disposition to issuer (D): 150 @ $221.50 · Disposition to issuer (D): 450 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 550 (derivative) · Disposition to issuer (D): 875 (derivative) · +6 moreEDGAR
2025-06-184Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 11,100 (derivative) @ $0EDGAR
2024-12-194Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 20,500 (derivative) @ $0EDGAR
2024-07-194Cidara Therapeutics, Inc. (CDTX)Grant/award (A): 2,125 (derivative) @ $0EDGAR
2024-05-244Arbutus Biopharma Corp (ABUS)Grant/award (A): 67,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1239650 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →